肥胖患者接受自体腹部游离皮瓣乳房重建的前瞻性评估
这项前瞻性分析纳入72例肥胖患者(平均年龄48.5岁,平均体重指数35.7 kg/m),共115个皮瓣行腹部游离皮瓣乳房重建。结果无皮瓣丢失,供区膨出/疝与历史对照无显著差异(p=0.86),皮瓣丢失率与历史对照亦无显著差异(p=0.061);作者认为可在肥胖患者中安全实施,但应就并发症风险充分告知。
要点
- 72例肥胖患者共115个腹部游离皮瓣,无皮瓣丢失。
- 供区膨出/疝与历史对照无显著差异(p=0.86)。
- 皮瓣丢失率与历史对照无显著差异(p=0.061)。
核心结论
- 肥胖患者可安全实施自体腹部游离皮瓣乳房重建,供区膨出/疝或皮瓣丢失风险较非肥胖患者未增加,但应就潜在并发症风险充分告知患者。
研究设计与样本
- 前瞻性分析肥胖患者接受自体乳房重建,共72例(平均年龄48.5岁,平均体重指数35.7 kg/m),115个皮瓣。
主要发现
- 72例中双侧重建43例,其余为单侧(n=115个皮瓣)。
- 皮瓣类型:保留肌肉的腹直肌肌皮瓣(TRAM)67个(58.3%)、腹壁下深穿支(DIEP)皮瓣44个(38.2%)、双蒂游离DIEP皮瓣2个、腹壁下浅穿支皮瓣1个、游离TRAM皮瓣1个。
- 42例(58.3%)有既往放疗,51例(70.8%)有既往化疗;43例(59.7%)为延期重建,21例(29.2%)为即刻重建;8例(11.1%)双侧重建中一侧即刻、另一侧延期;36例(半数)供区采用补片下层加强。
- 乳房并发症:伤口裂开11例、血肿1例、感染1例、乳房切除皮瓣坏死2例;供区伤口愈合并发症12例、感染4例、膨出/疝3例;无皮瓣丢失。
- 与历史对照比较,总体皮瓣丢失率无显著差异(p=0.061),供区膨出/疝无显著差异(p=0.86)。
临床怎么用
- 作者认为肥胖患者可安全实施自体腹部游离皮瓣乳房重建,但应就潜在并发症风险充分告知患者。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Obesity has been viewed as a relative contraindication against autologous free flap breast reconstruction because of increased risks of complications, including flap loss. METHODS: The authors conducted a prospective analysis of obese patients undergoing autologous breast reconstruction. RESULTS: Overall, 72 patients (average age, 48.5 years; average body mass index, 35.7 kg/m) underwent abdominal free flap breast reconstruction. There were 43 bilateral reconstructions and the remainder were unilateral (n = 115 flaps). There were 67 muscle-sparing transverse rectus abdominis musculocutaneous (TRAM) flaps (58.3 percent), 44 deep inferior epigastric perforator (DIEP) flaps (38.2 percent), two free bipedicle DIEP flaps, one superficial inferior epigastric perforator flap, and one free TRAM flap. Forty-two patients (58.3 percent) had prior radiation, and 51 (70.8 percent) had prior chemotherapy. Forty-three patients (59.7 percent) underwent delayed reconstruction and 21 (29.2 percent) underwent immediate reconstruction. Eight patients (11.1 percent) had bilateral reconstruction, with one breast reconstructed in an immediate and the other in a delayed fashion. Half of the patients (n = 36) had mesh placed in an underlay fashion to reinforce the donor site. Regarding breast complications, there were 11 wound dehiscences, one hematoma, one infection, and two patients with mastectomy skin flap necrosis. Twelve patients had donor-site wound healing complications, there were four infections, and three patients developed a bulge/hernia. There were no flap losses. Comparison to historic controls demonstrated no significant differences in overall flap loss rates (p = 0.061) or donor-site bulge/hernia (p = 0.86). CONCLUSION: Autologous abdominal free flaps can be performed safely in obese patients without increased risks for donor-site bulge/hernia or flap loss compared to nonobese patients; however, patients should be counseled carefully regarding the potential risks of complications. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.
引用
- Chang EI, Liu J. Prospective Evaluation of Obese Patients Undergoing Autologous Abdominal Free Flap Breast Reconstruction. Plast Reconstr Surg. 2018. PMID: 29794640. doi:10.1097/PRS.0000000000004550
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。